Advertisement

Topics

CARBOGEN AMCIS AG Company Profile

17:25 EDT 19th September 2018 | BioPortfolio

CARBOGEN AMCIS, recognized as world leader in the development chemistry market, provides world-class chemistry skills to provide seamless drug substance development and commercialization services. Dedicated to reducing the time, cost and risks associated with drug development, CARBOGEN AMCIS focus on supporting the development process from bench to market. We deliver integrated chemistry services that include: Early stage services such as process research and rapid API supply Late stage services such as process development and API manufacture for clinical trials and in-market supply Services As a world leader in chemistry development, we are committed to providing leading edge technologies and experienced personnel. In 2005, we served over 60 pharmaceutical firms, including seven of the 10 largest companies worldwide. Our work helps clients make critical decisions more efficiently and progresses drug candidates through the development pipeline more quickly.

Location

Hauptstrasse 171
Bubendorf
CH-4416
Switzerland

Contact

Phone: (+41) 61-935 53 53
Fax: (+41) 61-935 53 00
Email: info@carbogen-amcis.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Carbogen Amcis opens new Japanese office

Carbogen Amcis (Swiss-based pharma process development and API manufacturing company) has opened a new office located in Kyoto, Japan.

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Clinical trials targeting hypoxia.

The concept of tumour hypoxia as a cause of radiation resistance has been prevalent for over 100 years. During this time, our understanding of tumour hypoxia has matured with the recognition that oxyg...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carbogen and niacinamide may make tumor cells more sensitive to radiation therapy. It is not yet k...

Randomized Trial of ARCON in Larynx Cancer

TITLE: A multicentre, randomised, phase III clinical trial comparing accelerated radiotherapy with accelerated radiotherapy plus carbogen and nicotinamide (ARCON) in clinical stage T2-4 ...

Companies [3 Associated Companies listed on BioPortfolio]

CarboGen and AMCIS

CarboGen and AMCIS, recognized as world leaders in the development chemistry market, combine world-class chemistry skills to provide seamless drug substance development and commercialization services....

CARBOGEN AMCIS AG

CARBOGEN AMCIS, recognized as world leader in the development chemistry market, provides world-class chemistry skills to provide seamless drug substance development and commercialization services. D...

CarboGen Laboratories

Faster-to-Market is the top priority of research-based pharmaceutical companies. CarboGen is a company that specializes in helping these companies accomplish this. For the last ten years CarboGen has ...

More Information about "CARBOGEN AMCIS AG" on BioPortfolio

We have published hundreds of CARBOGEN AMCIS AG news stories on BioPortfolio along with dozens of CARBOGEN AMCIS AG Clinical Trials and PubMed Articles about CARBOGEN AMCIS AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CARBOGEN AMCIS AG Companies in our database. You can also find out about relevant CARBOGEN AMCIS AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record